We assessed whether omega-3 index (red blood cell concentrations of
eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA)) was associated with
insulin sensitivity and other metabolic outcomes in 47
overweight men aged 46.5 ± 5.1 years. Participants were assessed twice, 16 weeks apart.
Insulin sensitivity was assessed by the Matsuda method from an oral
glucose tolerance test. Linear associations were examined; stratified analyses were carried out with participants separated according to the omega-3 index: lower tertiles (LOI; n = 31) and highest tertile (
HOI; n = 16). Increasing omega-3 index was correlated with higher
insulin sensitivity (r = 0.23; p = 0.025), higher disposition index (r = 0.20; p = 0.054), and lower CRP concentrations (r = -0.39; p < 0.0001).
Insulin sensitivity was 43% higher in
HOI than in LOI men (Matsuda index 6.83 vs 4.78; p = 0.009). Similarly,
HOI men had disposition index that was 70% higher (p = 0.013) and fasting
insulin concentrations 25% lower (p = 0.038).
HOI men displayed lower nocturnal systolic blood pressure (-6.0 mmHg; p = 0.025) and greater systolic blood pressure dip (14.7 vs 10.8%; p = 0.039). Men in the
HOI group also had lower concentrations of CRP (41% lower; p = 0.033) and
free fatty acids (21% lower, p = 0.024). In conclusion, higher omega-3 index is associated with increased
insulin sensitivity and a more favourable metabolic profile in middle-aged
overweight men.